Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58).
Cell-penetrating peptides (CPPs) are able to translocate problematic therapeutic cargoes across cellular membranes. The exact mechanisms of translocation are still under investigation. However, evidence for endocytic uptake is increasing. We investigated the interactions of CPPs with phospholipid bilayers as first step of translocation. To this purpose, we employed four independent techniques, comprising (i) liposome buffer equilibrium dialysis, (ii) Trp fluorescence quenching, (iii) fluorescence polarization, and (iv) determination of zeta-potentials. Using unilamellar vesicles (LUVs) of different phospholipid composition, we compared weakly cationic human calcitonin (hCT)-derived peptides with the oligocationic CPPs pVEC and penetratin (pAntp). Apparent partition coefficients of hCT-derived peptides in neutral POPC LUVs were dependent on amino acid composition and secondary structure; partitioning in negatively charged POPC/POPG (80:20) LUVs was increased and mainly governed by electrostatic interactions. For hCT(9-32) and its derivatives, D values raised from about 100-200 in POPC to about 1000 to 1500 when negatively charged lipids were present. Localization profiles of CPPs obtained by Trp fluorescence quenching were dependent on the charge density of LUVs. In POPC/POPG, hCT-derived CPPs were located on the bilayer surface, whereas pVEC and pAntp resided deeper in the membrane. In POPG LUVs, an increase of fluorescence polarization was observed for pVEC and pAntp but not for hCT-derived peptides. Generally, we found strong peptide-phospholipid interactions, especially when negatively charged lipids were present.
Herbig
Michael E
ME
Drug Formulation and Delivery Group, Department of Chemistry and Applied BioSciences, Swiss Federal Institute of Technology Zurich (ETH Zurich), Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland.
Fromm
Ursina
U
Leuenberger
Jeannine
J
Krauss
Ulrike
U
Beck-Sickinger
Annette G
AG
Merkle
Hans P
HP
D020106:Acrylamide / Q000737:chemistry; D000595:Amino Acid Sequence; D015703:Antigens, CD; D001669:Biochemical Phenomena; D001671:Biochemistry; D015820:Cadherins / Q000737:chemistry; D002116:Calcitonin / Q000737:chemistry* / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008027:Light; D008051:Lipid Bilayers / Q000737:chemistry*; D008055:Lipids / Q000737:chemistry; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism; D008823:Micelles; D008856:Microscopy, Fluorescence; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry*; D010713:Phosphatidylcholines / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry; D012542:Scattering, Radiation; D013050:Spectrometry, Fluorescence; D013696:Temperature; D000099152:Cadherin 5
D020106:Acrylamide; D015703:Antigens, CD; D015820:Cadherins; D002116:Calcitonin; D008051:Lipid Bilayers; D008055:Lipids; D008081:Liposomes; D008823:Micelles; D010455:Peptides; D010713:Phosphatidylcholines; D010743:Phospholipids; D000099152:Cadherin 5; C028694:1-palmitoyl-2-oleoylphosphatidylcholine